Liver biopsy

被引：33

作者：

Bedossa, P. ^{[1
]}

机构：

[1] Univ Paris 07, Beaujon Hosp, Dept Pathol, F-75221 Paris 05, France

来源：

GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2008年 / 32卷

关键词：

Biopsy; Extracellular matrix; Sampling variation; Histopathology; METAVIR;

D O I：

10.1016/S0399-8320(08)73989-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Fibrosis, the excess deposition of extracellutar matrix in the Liver is a form of anatomical damage to the liver parenchyma, so that liver biopsy is the only approach for its direct assessment. Although liver biopsy has its limitations, appropriate precautions can reduce the flaws inherent in this method. The level. of accuracy obtained with biopsy is particularly important for obtaining a starting point in patients with chronic liver disease who are to be followed-up over a number of years. Therefore, liver biopsy has been used as the gold standard to establish algorithm combinations of biological tests. As well. as an accurate assessment of the extent of Liver fibrosis, the biopsy can reveal other informations and associated features relevant to evaluation of the fibrotic process. (C) 2008 Elsevier Masson SAS. All rights reserved.

引用

页码：4 / 7

页数：4

共 25 条

[1] The practice of percutaneous liver biopsy in a gastrohepatology day hospital: A retrospective study on 835 biopsies [J].

Actis, Giovanni Clemente ;

Olivero, Alda ;

Lagget, Marco ;

Pellicano, Rinaldo ;

Smedile, Antonina ;

Rizzetto, Mario .

DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (10) :2576-2579

[2] Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C [J].

Asselah, T. ;

Bieche, I. ;

Narguet, S. ;

Sabbagh, A. ;

Laurendeau, I. ;

Ripault, M-P ;

Boyer, N. ;

Martinot-Peignoux, M. ;

Valla, D. ;

Vidaud, M. ;

Marcellin, P. .

GUT, 2008, 57 (04) :516-524

[3] An algorithm for the grading of activity in chronic hepatitis C [J].

Bedossa, P ;

Poynard, T .

HEPATOLOGY, 1996, 24 (02) :289-293

[4] Sampling variability of liver fibrosis in chronic hepatitis C [J].

Bedossa, P ;

Dargère, D ;

Paradis, V .

HEPATOLOGY, 2003, 38 (06) :1449-1457

[5]

BEDOSSA P, 1994, HEPATOLOGY, V20, P15

[6] Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study [J].

Bedossa, Pierre ;

Moucari, Rami ;

Chelbi, Emna ;

Asselah, Tarik ;

Paradis, Valerie ;

Vidaud, Michel ;

Cazals-Hatem, Dominique ;

Boyer, Nathalie ;

Valla, Dominique ;

Marcellin, Patrick .

HEPATOLOGY, 2007, 46 (02) :380-387

[7] Practices of liver biopsy in France: Results of a prospective nationwide survey [J].

Cadranel, JF ;

Rufat, P ;

Degos, F .

HEPATOLOGY, 2000, 32 (03) :477-481

[8] Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C [J].

Cisneros, Laura ;

Londono, Maria-Carlota ;

Blasco, Carmen ;

Bataller, Ramon ;

Miquel, Rosa ;

Bruguera, Miquel ;

Gines, Pere ;

Rimola, Antoni .

LIVER TRANSPLANTATION, 2007, 13 (07) :1017-1027

[9] Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease [J].

Colloredo, G ;

Guido, M ;

Sonzogni, A ;

Leandro, G .

JOURNAL OF HEPATOLOGY, 2003, 39 (02) :239-244

[10] Impact of steatosis on progression of fibrosis in patients with mild hepatitis C [J].

Fartoux, L ;

Chazouillères, O ;

Wendum, D ;

Poupon, R ;

Serfaty, L .

HEPATOLOGY, 2005, 41 (01) :82-87

← 1 2 3 →